CorMedix Inc.
CRMDNASDAQHealthcare● Active
$8.54
+$0.18(+2.15%)
Market Cap$669979149
P/E Ratio—
52W High$17.43
52W Low$6.13
CorMedix Inc. (CRMD) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CRMD · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.31B | $0.04B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.04B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.28B | $0.04B | ($0.00B) | $0.00B | $0.00B |
| Gross Margin %(computed) | 88.46% | 92.66% | — | 94.29% | 22.00% |
| Operating Expenses | |||||
| R&D Expenses | $0.02B | $0.00B | $0.01B | $0.01B | $0.01B |
| G&A Expenses | $0.07B | $0.03B | $0.02B | $0.00B | $0.00B |
| Total Operating Expenses | $0.13B | $0.06B | $0.05B | $0.03B | $0.03B |
| Operating Income | $0.15B | ($0.02B) | ($0.05B) | ($0.03B) | ($0.03B) |
| Operating Margin %(computed) | 48.17% | -51.43% | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.15B | ($0.02B) | ($0.05B) | ($0.03B) | ($0.03B) |
| Income Tax Expense | ($0.01B) | ($0.00B) | $0.00B | ($0.00B) | ($0.00B) |
| Net Income | $0.16B | ($0.02B) | ($0.05B) | ($0.03B) | ($0.03B) |
| Net Margin %(computed) | 52.31% | -41.24% | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $2.25 | $-0.30 | $-0.91 | $-0.74 | $-0.75 |
| Wtd Avg Shares | 0.07B | 0.06B | 0.05B | 0.04B | 0.04B |
| EBITDA | $0.17B | ($0.02B) | ($0.05B) | ($0.03B) | ($0.03B) |
| EBITDA Margin %(computed) | 52.98% | -43.66% | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more CorMedix Inc. data
About CorMedix Inc. (CRMD) Income Statement
CorMedix Inc. (CRMD) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CRMD reported revenue of $0.31B, gross profit of $0.28B (gross margin 88.46%), and net income of $0.16B — a net profit margin of 52.31%.
Frequently asked questions
CRMD · 4 questionsCorMedix Inc. (CRMD) reported revenue of $0.31B for 2025, up 617.0% year-over-year.
CRMD revenueCRMD salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09